AMANDA RILEY: Open Payments
NPI 1992126775 · BUTLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,042 in 105 payments from 27 companies in 2025. Trend: 2023 $1,645 · 2024 $2,097 · 2025 $2,042
Food & beverage: $2,042
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $403 |
| Amgen Inc. | 18 | $231 |
| Insulet Corporation | 7 | $169 |
| Lilly USA, LLC | 10 | $141 |
| Novartis Pharmaceuticals Corporation | 10 | $138 |
| Tandem Diabetes Care, Inc. | 4 | $103 |
| Corcept Therapeutics | 5 | $96 |
| CeQur Corporation | 1 | $78 |
| Radius Health, Inc. | 3 | $77 |
| Abbott Laboratories | 3 | $54 |
Products named: Ozempic, TEPEZZA, Omnipod, LEQVIO, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Korlym, CeQur Simplicity.
Industry payments across GA — which companies pay providers there.
